These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 31009968

  • 1. Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence.
    MacDiarmid S, Staskin DR, Lucente V, Kaaki B, English S, Gilling P, Meffan P, Clark M, Sand PK, Sen SK, Rovner E.
    J Urol; 2019 May; 201(5):967-972. PubMed ID: 31009968
    [Abstract] [Full Text] [Related]

  • 2. Twelve-month Durability of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence: A Single-Arm, Prospective Study.
    Gilling P, Meffan P, Kaaki B, MacDiarmid S, Lucente V, Clark M, Sen SK, English S, Sand PK.
    Urology; 2021 Nov; 157():71-78. PubMed ID: 34048826
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Six-Month Outcomes of Reimplantation of a Coin-Sized Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome With Urgency Urinary Incontinence.
    Kaaki B, English S, Gilling P, Meffan P, Lucente V, MacDiarmid S, Clark M, Sen SK.
    Female Pelvic Med Reconstr Surg; 2022 May 01; 28(5):287-292. PubMed ID: 35536667
    [Abstract] [Full Text] [Related]

  • 5. A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaints.
    Heesakkers JPFA, Digesu GA, van Breda J, Van Kerrebroeck P, Elneil S.
    Neurourol Urodyn; 2018 Mar 01; 37(3):1060-1067. PubMed ID: 28892221
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.
    Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA.
    J Urol; 2013 Jun 01; 189(6):2194-201. PubMed ID: 23219541
    [Abstract] [Full Text] [Related]

  • 8. Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation.
    Siegel S, Noblett K, Mangel J, Bennett J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Zylstra S, Kan F, Berg KC.
    J Urol; 2018 Jan 01; 199(1):229-236. PubMed ID: 28709886
    [Abstract] [Full Text] [Related]

  • 9. One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinence.
    Benson K, McCrery R, Taylor C, Padron O, Blok B, de Wachter S, Pezzella A, Gruenenfelder J, Pakzad M, Perrouin-Verbe MA, Van Kerrebroeck P, Mangel J, Peters K, Kennelly M, Shapiro A, Lee U, Comiter C, Mueller M, Goldman H, Lane F.
    Neurourol Urodyn; 2020 Jun 01; 39(5):1482-1488. PubMed ID: 32339339
    [Abstract] [Full Text] [Related]

  • 10. A New Implanted Posterior Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome: 3-Month Results of a Novel Therapy at a Single Center.
    van Breda HMK, Martens FMJ, Tromp J, Heesakkers JPFA.
    J Urol; 2017 Jul 01; 198(1):205-210. PubMed ID: 28189576
    [Abstract] [Full Text] [Related]

  • 11. Treatment of Urinary Urgency Incontinence Using a Rechargeable SNM System: 6-Month Results of the ARTISAN-SNM Study.
    McCrery R, Lane F, Benson K, Taylor C, Padron O, Blok B, De Wachter S, Pezzella A, Gruenenfelder J, Pakzad M, Perrouin-Verbe MA, Le Normand L, Van Kerrebroeck P, Mangel J, Peters K, Kennelly M, Shapiro A, Lee U, Comiter C, Mueller M, Goldman HB.
    J Urol; 2020 Jan 01; 203(1):185-192. PubMed ID: 31347955
    [Abstract] [Full Text] [Related]

  • 12. A Multicenter Study Evaluating the FREquency of Use and Efficacy of a Novel Closed-Loop Wearable Tibial Neuromodulation System for Overactive Bladder and Urgency Urinary Incontinence (FREEOAB).
    Goudelocke C, Sobol J, Poulos D, Enemchukwu E, Zaslau S, Dhir R.
    Urology; 2024 Jan 01; 183():63-69. PubMed ID: 37944596
    [Abstract] [Full Text] [Related]

  • 13. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M, Crampton J.
    Physiotherapy; 2019 Dec 01; 105(4):469-475. PubMed ID: 30862384
    [Abstract] [Full Text] [Related]

  • 14. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder.
    Noblett K, Siegel S, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Kan F, Berg KC.
    Neurourol Urodyn; 2016 Feb 01; 35(2):246-51. PubMed ID: 25546568
    [Abstract] [Full Text] [Related]

  • 15. OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial.
    Amundsen CL, Richter HE, Menefee SA, Komesu YM, Arya LA, Gregory WT, Myers DL, Zyczynski HM, Vasavada S, Nolen TL, Wallace D, Meikle SF.
    JAMA; 2016 Oct 04; 316(13):1366-1374. PubMed ID: 27701661
    [Abstract] [Full Text] [Related]

  • 16. Development of an implant technique and early experience using a novel implantable pulse generator with a quadripolar electrode array at the tibial nerve for refractory overactive bladder.
    Sirls LT, Schonhoff A, Waldvogel A, Peters KM.
    Neurourol Urodyn; 2023 Feb 04; 42(2):427-435. PubMed ID: 36573835
    [Abstract] [Full Text] [Related]

  • 17. Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence.
    Richter HE, Amundsen CL, Erickson SW, Jelovsek JE, Komesu Y, Chermansky C, Harvie HS, Albo M, Myers D, Gregory WT, Wallace D, NICHD Pelvic Floor Disorders Network.
    J Urol; 2017 Oct 04; 198(4):890-896. PubMed ID: 28501541
    [Abstract] [Full Text] [Related]

  • 18. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
    Chapple C, Schneider T, Haab F, Sun F, Whelan L, Scholfield D, Dragon E, Mangan E.
    BJU Int; 2014 Sep 04; 114(3):418-26. PubMed ID: 24552358
    [Abstract] [Full Text] [Related]

  • 19. Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial.
    Amundsen CL, Komesu YM, Chermansky C, Gregory WT, Myers DL, Honeycutt EF, Vasavada SP, Nguyen JN, Wilson TS, Harvie HS, Wallace D, Pelvic Floor Disorders Network.
    Eur Urol; 2018 Jul 04; 74(1):66-73. PubMed ID: 29482936
    [Abstract] [Full Text] [Related]

  • 20. Tibial Nerve Stimulation for Urge Urinary Incontinence and Overactive Bladder: Narrative Review of Randomized Controlled Trials and Applicability to Implantable Devices.
    Lee UJ, MacDiarmid S, Matthews CA, Gillespie E, Peters KM.
    Adv Ther; 2024 Jul 04; 41(7):2635-2654. PubMed ID: 38748331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.